Vericel VCEL
NASDAQ VCEL
$40.11 -0.36 (-0.89%)
As of: Sep 4, 2026 · 3:57 PM EDT

Vericel (VCEL) EBITDA (2010 - 2026)

Vericel (VCEL) posted EBITDA of $434000.0 for Q2 2026, up 105.38% sequentially from -$8.1 million in Q1 2026, and up 121.39% YoY from $196034.3 in Q2 2025.

Analysis

Vericel (VCEL) EBITDA (2010 - 2026) Analysis & Trends

Vericel has reported EBITDA for 17 years, with the latest figure at $434000.0 in Q2 2026.

  • Quarterly EBITDA rose 121.39% year-over-year to $434000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.2 million (up 1428.5% YoY) and the FY2025 annual result came in at $11.0 million, up 144.39% from the prior year.
  • EBITDA improved to $434000.0 in Q2 2026 per VCEL's latest filing, from -$8.1 million in the prior quarter.
  • Over five years, EBITDA peaked at $22.4 million in Q4 2025 and troughed at -$12.8 million in Q1 2025.
  • A 5-year average of -$866055.6 and a median of -$5.3 million in 2023 frame the typical range for EBITDA.
  • The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 143.55% in 2022, then soared 239.96% in 2025.
  • Over 5 years, EBITDA stood at $6.1 million in 2022, then surged by 109.22% to $12.7 million in 2023, then soared by 45.15% to $18.5 million in 2024, then rose by 21.3% to $22.4 million in 2025, then slumped by 98.06% to $434000.0 in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered $434000.0, -$8.1 million, and $22.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 434,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 434,000.00
Mar 31, 2026 -8.06 Mn
Dec 31, 2025 22.42 Mn
Sep 30, 2025 3.45 Mn
Jun 30, 2025 -2.03 Mn
Mar 31, 2025 -12.79 Mn
Dec 31, 2024 18.48 Mn
Sep 30, 2024 -2.47 Mn
Jun 30, 2024 -6.03 Mn
Mar 31, 2024 -5.46 Mn
Dec 31, 2023 12.73 Mn
Sep 30, 2023 -5.06 Mn
Jun 30, 2023 -5.96 Mn
Mar 31, 2023 -8.18 Mn
Dec 31, 2022 6.09 Mn
Sep 30, 2022 -6.79 Mn
Jun 30, 2022 -9.08 Mn
Mar 31, 2022 -7.27 Mn
Dec 31, 2021 4.14 Mn
Sep 30, 2021 -4.96 Mn